Ion News and Research

RSS

COPD: Ion channels in immune cells could potentially be targets for new therapies

Chronic obstructive pulmonary disease – COPD for short – is one of the most common diseases of the lung. It affects almost 300 million people worldwide, of which about three million die every year.

17 Jan 2022

Manipulating voltage patterns in tumor cells reduces breast cancer metastasis in animal models

In normal cells, electrical voltage patterns provide a blueprint for orderly growth. But with cancer, the opposite happens.

11 Jan 2022

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

The neuromuscular junction - where nerves and muscle fibers meet - is an essential synapse for muscle contraction and movement.

6 Jan 2022

Research may pave the way for designing new therapies to combat schistosomiasis

Neglected tropical diseases (NTDs) represent a group of about 20 conditions that affect more than a billion people worldwide.

6 Jan 2022

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers, led by Penn State, have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.

6 Jan 2022

New MXene-based wearable sensor may help athletes with real-time performance measurements

Ultrathin nanomaterials, known as MXenes, are poised to make it easier to monitor a person's well-being by analyzing their perspiration.

3 Jan 2022

Research suggests targeting fusion peptide-calcium interaction may help treat COVID-19

Researchers discovered that the entry of coronaviruses is a Ca2+-dependent process and focused their studies on the SARS-1 FP-Ca2+ interaction and its effect on membranes using electron spin resonance (ESR).

10 Dec 2021

Optimizing the treatment of epilepsy patients

Researchers have devised a new diagnostic model to predict how generalized epilepsy patients will respond to drug treatment.

8 Dec 2021

Metrion Biosciences expands ion channel drug discovery service capabilities and in-house expertise

Metrion today announced it has expanded its capabilities and expertise through the addition of automated low volume liquid handling capability.

From Metrion Biosciences Limited 7 Dec 2021

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.

2 Dec 2021

Protein found in rattlesnake venom used for making a drug candidate to modulate blood clotting

Researchers in Brazil and Belgium have developed a molecule of pharmaceutical interest from collinein-1, a protein found in rattlesnake venom.

1 Dec 2021

Study reports first-ever modeling of the electrical activity of circadian clock neurons in diurnal species

It's no secret that jet lag and night-shift work can wreak havoc on the way our body's internal clock syncs up our daily wake-sleep cycle, known as circadian rhythm, but now researchers say they are a step closer to understanding how the brain creates behavioral rhythms optimized for diurnal, rather than nocturnal, life.

30 Nov 2021

Study uncovers important genetic predispositions for acute myeloid leukemia

The National Center for Tumor Diseases Dresden is a joint institution of the German Cancer Research Center, the University Hospital Carl Gustav Carus Dresden, Carl Gustav Carus Faculty of Medicine at TU Dresden and the Helmholtz-Zentrum Dresden-Rossendorf.

24 Nov 2021

Ion News and Research

COPD: Ion channels in immune cells could potentially be targets for new therapies

Manipulating voltage patterns in tumor cells reduces breast cancer metastasis in animal models

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Research may pave the way for designing new therapies to combat schistosomiasis

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

New MXene-based wearable sensor may help athletes with real-time performance measurements

Research suggests targeting fusion peptide-calcium interaction may help treat COVID-19

Optimizing the treatment of epilepsy patients

Metrion Biosciences expands ion channel drug discovery service capabilities and in-house expertise

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Protein found in rattlesnake venom used for making a drug candidate to modulate blood clotting

Study reports first-ever modeling of the electrical activity of circadian clock neurons in diurnal species

Study uncovers important genetic predispositions for acute myeloid leukemia

Human lung airway-on-a-chip faithfully recapitulates cystic fibrosis pathology

NAU team receives $3 million from NSF to translate the codex contained in algal microbiome

Functions of glycosylation in SARS-CoV-2 proteins and human receptor ACE2

Proposed acquisition of Life Sciences manufacturer Adaptas Solutions for $271m

Research expands the general understanding of transcription process in bacteria

Researchers develop a rapid, non-invasive exhaled breath screening system for COVID-19

Researchers discover mechanisms underlying the unwanted side effects of drugs

Enhancing confidence in chemical ionization spectrometry data eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News